Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$411,404
+$77,528 QoQ
Shares Held
343
-5.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#3,919
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fort Point Capital Partners LLC holds $5,958,387 across 7 Drug Manufacturers - General names. LLY ranks #5 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
7,549 | $1,899,630 | |
| 2 | MRK |
Merck & Co., Inc.
|
7,670 | $985,595 | |
| 3 | AMGN |
Amgen Inc
|
2,701 | $978,086 | |
| 4 | JNJ |
Johnson & Johnson
|
3,548 | $901,085 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
343 | $411,404 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,249 | $410,478 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,458 | $372,109 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $411,404 | 343 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $333,876 | 363 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $391,183 | 364 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $868,396 | 1,114 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $887,027 | 1,074 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $863,096 | 1,118 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,038,321 | 1,172 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $895,420 | 989 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,939,454 | 2,493 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,459,048 | 2,503 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,341,750 | 2,498 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,083,812 | 2,311 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $774,755 | 2,256 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $816,189 | 2,231 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $730,124 | 2,258 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $732,759 | 2,260 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $683,278 | 2,386 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $624,533 | 2,261 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $523,559 | 2,266 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $372,970 | 1,625 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $303,395 | 1,624 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $324,848 | 1,924 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $317,354 | 2,144 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $328,360 | 2,000 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $282,988 | 2,040 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||